Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,183.06
(
2.72%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.15
(
0.33%
)
Bitcoin
71,040.60
(
-0.13%
)
News Focus
News Focus
Post# of 517005
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

tradeherpete

Send PM Follow Ignore
Followers 55
Posts 4220
Boards Moderated 0
Alias Born 03/20/2014

tradeherpete

Re: DoTheRightThing post# 407616

Friday, 03/17/2023 1:00:03 PM

Friday, March 17, 2023 1:00:03 PM

Post# of 517005
By not acknowledging Anavex accomplishments to date, which can be readily seen by the lack of respect offered to Dr. Missling and Company, you undermine your assertions.

Why should long time investors, or anyone, listen to rhetoric generated by such a questionable source?

Dr. Missling and Company are advancing the benefits of the S-1R receptor, as no one else has come close to doing. The Sigma One Platform will support a new era in CNS therapeutics.

Rushing this process seems less advisable than following a sensible plan.

All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News